Report Overview
Report Overview
Gene therapy is a medical approach that treats or prevents disease by correcting the underlying genetic problem. Gene therapy techniques allow doctors to treat a disorder by altering a persons genetic makeup instead of using drugs or surgery.Advances in gene therapy technology, increasing understanding of genetics, and the potential for addressing previously untreatable diseases contribute to the growth of the Human Gene Therapy market.
The global Human Gene Therapy market size was estimated at USD 5677.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Human Gene Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Human Gene Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Human Gene Therapy market.
Global Human Gene Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Biogen
Sarepta Therapeutics
Gilead Sciences
Amgen
Novartis
Orchard Therapeutics
Spark Therapeutics
Agc Biologics
Anges
Bluebird Bio
Jazz Pharmaceuticals
Dynavax Technologies
Human Stem Cells Institute
Sibiono Genetech
Shanghai Sunway Biotech
Uniqure N.V.
Gensight Biologics S.A.
Celgene Corporation
Cellectis
Sangamo Therapeutics
Mustang Bio
AGTC
Poseida Therapeutics
Market Segmentation (by Type)
Non-viral Vectors
Viral Vectors
Market Segmentation (by Application)
Neurological Diseases
Cancer
DMD (Duchenne Muscular Dystrophy)
Hepatological Diseases
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Human Gene Therapy Market
Overview of the regional outlook of the Human Gene Therapy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Human Gene Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Table of Contents
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Human Gene Therapy
- 1.2 Key Market Segments
- 1.2.1 Human Gene Therapy Segment by Type
- 1.2.2 Human Gene Therapy Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Human Gene Therapy Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Human Gene Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
- 2.1.2 Global Human Gene Therapy Sales Estimates and Forecasts (2020-2035)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 2.1 Global Market Overview
- 3 Human Gene Therapy Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Human Gene Therapy Product Life Cycle
- 3.3 Global Human Gene Therapy Sales by Manufacturers (2020-2025)
- 3.4 Global Human Gene Therapy Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Human Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Human Gene Therapy Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
- 3.8 Human Gene Therapy Market Competitive Situation and Trends
- 3.8.1 Human Gene Therapy Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Human Gene Therapy Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Human Gene Therapy Industry Chain Analysis
- 4.1 Human Gene Therapy Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Human Gene Therapy Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Human Gene Therapy Market Porters Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy ? April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Human Gene Therapy Market
- 5.7 ESG Ratings of Leading Companies
- 6 Human Gene Therapy Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Human Gene Therapy Sales Market Share by Type (2020-2025)
- 6.3 Global Human Gene Therapy Market Size by Type (2020-2025)
- 6.4 Global Human Gene Therapy Price by Type (2020-2025)
- 7 Human Gene Therapy Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Human Gene Therapy Market Sales by Application (2020-2025)
- 7.3 Global Human Gene Therapy Market Size (M USD) by Application (2020-2025)
- 7.4 Global Human Gene Therapy Sales Growth Rate by Application (2020-2025)
- 8 Human Gene Therapy Market Sales by Region
- 8.1 Global Human Gene Therapy Sales by Region
- 8.1.1 Global Human Gene Therapy Sales by Region
- 8.1.2 Global Human Gene Therapy Sales Market Share by Region
- 8.2 Global Human Gene Therapy Market Size by Region
- 8.2.1 Global Human Gene Therapy Market Size by Region
- 8.2.2 Global Human Gene Therapy Market Size by Region
- 8.3 North America
- 8.3.1 North America Human Gene Therapy Sales by Country
- 8.3.2 North America Human Gene Therapy Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Human Gene Therapy Sales by Country
- 8.4.2 Europe Human Gene Therapy Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Human Gene Therapy Sales by Region
- 8.5.2 Asia Pacific Human Gene Therapy Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Human Gene Therapy Sales by Country
- 8.6.2 South America Human Gene Therapy Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Human Gene Therapy Sales by Region
- 8.7.2 Middle East and Africa Human Gene Therapy Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 8.1 Global Human Gene Therapy Sales by Region
- 9 Human Gene Therapy Market Production by Region
- 9.1 Global Production of Human Gene Therapy by Region(2020-2025)
- 9.2 Global Human Gene Therapy Revenue Market Share by Region (2020-2025)
- 9.3 Global Human Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Human Gene Therapy Production
- 9.4.1 North America Human Gene Therapy Production Growth Rate (2020-2025)
- 9.4.2 North America Human Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Human Gene Therapy Production
- 9.5.1 Europe Human Gene Therapy Production Growth Rate (2020-2025)
- 9.5.2 Europe Human Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Human Gene Therapy Production (2020-2025)
- 9.6.1 Japan Human Gene Therapy Production Growth Rate (2020-2025)
- 9.6.2 Japan Human Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Human Gene Therapy Production (2020-2025)
- 9.7.1 China Human Gene Therapy Production Growth Rate (2020-2025)
- 9.7.2 China Human Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Biogen
- 10.1.1 Biogen Basic Information
- 10.1.2 Biogen Human Gene Therapy Product Overview
- 10.1.3 Biogen Human Gene Therapy Product Market Performance
- 10.1.4 Biogen Business Overview
- 10.1.5 Biogen SWOT Analysis
- 10.1.6 Biogen Recent Developments
- 10.2 Sarepta Therapeutics
- 10.2.1 Sarepta Therapeutics Basic Information
- 10.2.2 Sarepta Therapeutics Human Gene Therapy Product Overview
- 10.2.3 Sarepta Therapeutics Human Gene Therapy Product Market Performance
- 10.2.4 Sarepta Therapeutics Business Overview
- 10.2.5 Sarepta Therapeutics SWOT Analysis
- 10.2.6 Sarepta Therapeutics Recent Developments
- 10.3 Gilead Sciences
- 10.3.1 Gilead Sciences Basic Information
- 10.3.2 Gilead Sciences Human Gene Therapy Product Overview
- 10.3.3 Gilead Sciences Human Gene Therapy Product Market Performance
- 10.3.4 Gilead Sciences Business Overview
- 10.3.5 Gilead Sciences SWOT Analysis
- 10.3.6 Gilead Sciences Recent Developments
- 10.4 Amgen
- 10.4.1 Amgen Basic Information
- 10.4.2 Amgen Human Gene Therapy Product Overview
- 10.4.3 Amgen Human Gene Therapy Product Market Performance
- 10.4.4 Amgen Business Overview
- 10.4.5 Amgen Recent Developments
- 10.5 Novartis
- 10.5.1 Novartis Basic Information
- 10.5.2 Novartis Human Gene Therapy Product Overview
- 10.5.3 Novartis Human Gene Therapy Product Market Performance
- 10.5.4 Novartis Business Overview
- 10.5.5 Novartis Recent Developments
- 10.6 Orchard Therapeutics
- 10.6.1 Orchard Therapeutics Basic Information
- 10.6.2 Orchard Therapeutics Human Gene Therapy Product Overview
- 10.6.3 Orchard Therapeutics Human Gene Therapy Product Market Performance
- 10.6.4 Orchard Therapeutics Business Overview
- 10.6.5 Orchard Therapeutics Recent Developments
- 10.7 Spark Therapeutics
- 10.7.1 Spark Therapeutics Basic Information
- 10.7.2 Spark Therapeutics Human Gene Therapy Product Overview
- 10.7.3 Spark Therapeutics Human Gene Therapy Product Market Performance
- 10.7.4 Spark Therapeutics Business Overview
- 10.7.5 Spark Therapeutics Recent Developments
- 10.8 Agc Biologics
- 10.8.1 Agc Biologics Basic Information
- 10.8.2 Agc Biologics Human Gene Therapy Product Overview
- 10.8.3 Agc Biologics Human Gene Therapy Product Market Performance
- 10.8.4 Agc Biologics Business Overview
- 10.8.5 Agc Biologics Recent Developments
- 10.9 Anges
- 10.9.1 Anges Basic Information
- 10.9.2 Anges Human Gene Therapy Product Overview
- 10.9.3 Anges Human Gene Therapy Product Market Performance
- 10.9.4 Anges Business Overview
- 10.9.5 Anges Recent Developments
- 10.10 Bluebird Bio
- 10.10.1 Bluebird Bio Basic Information
- 10.10.2 Bluebird Bio Human Gene Therapy Product Overview
- 10.10.3 Bluebird Bio Human Gene Therapy Product Market Performance
- 10.10.4 Bluebird Bio Business Overview
- 10.10.5 Bluebird Bio Recent Developments
- 10.11 Jazz Pharmaceuticals
- 10.11.1 Jazz Pharmaceuticals Basic Information
- 10.11.2 Jazz Pharmaceuticals Human Gene Therapy Product Overview
- 10.11.3 Jazz Pharmaceuticals Human Gene Therapy Product Market Performance
- 10.11.4 Jazz Pharmaceuticals Business Overview
- 10.11.5 Jazz Pharmaceuticals Recent Developments
- 10.12 Dynavax Technologies
- 10.12.1 Dynavax Technologies Basic Information
- 10.12.2 Dynavax Technologies Human Gene Therapy Product Overview
- 10.12.3 Dynavax Technologies Human Gene Therapy Product Market Performance
- 10.12.4 Dynavax Technologies Business Overview
- 10.12.5 Dynavax Technologies Recent Developments
- 10.13 Human Stem Cells Institute
- 10.13.1 Human Stem Cells Institute Basic Information
- 10.13.2 Human Stem Cells Institute Human Gene Therapy Product Overview
- 10.13.3 Human Stem Cells Institute Human Gene Therapy Product Market Performance
- 10.13.4 Human Stem Cells Institute Business Overview
- 10.13.5 Human Stem Cells Institute Recent Developments
- 10.14 Sibiono Genetech
- 10.14.1 Sibiono Genetech Basic Information
- 10.14.2 Sibiono Genetech Human Gene Therapy Product Overview
- 10.14.3 Sibiono Genetech Human Gene Therapy Product Market Performance
- 10.14.4 Sibiono Genetech Business Overview
- 10.14.5 Sibiono Genetech Recent Developments
- 10.15 Shanghai Sunway Biotech
- 10.15.1 Shanghai Sunway Biotech Basic Information
- 10.15.2 Shanghai Sunway Biotech Human Gene Therapy Product Overview
- 10.15.3 Shanghai Sunway Biotech Human Gene Therapy Product Market Performance
- 10.15.4 Shanghai Sunway Biotech Business Overview
- 10.15.5 Shanghai Sunway Biotech Recent Developments
- 10.16 Uniqure N.V.
- 10.16.1 Uniqure N.V. Basic Information
- 10.16.2 Uniqure N.V. Human Gene Therapy Product Overview
- 10.16.3 Uniqure N.V. Human Gene Therapy Product Market Performance
- 10.16.4 Uniqure N.V. Business Overview
- 10.16.5 Uniqure N.V. Recent Developments
- 10.17 Gensight Biologics S.A.
- 10.17.1 Gensight Biologics S.A. Basic Information
- 10.17.2 Gensight Biologics S.A. Human Gene Therapy Product Overview
- 10.17.3 Gensight Biologics S.A. Human Gene Therapy Product Market Performance
- 10.17.4 Gensight Biologics S.A. Business Overview
- 10.17.5 Gensight Biologics S.A. Recent Developments
- 10.18 Celgene Corporation
- 10.18.1 Celgene Corporation Basic Information
- 10.18.2 Celgene Corporation Human Gene Therapy Product Overview
- 10.18.3 Celgene Corporation Human Gene Therapy Product Market Performance
- 10.18.4 Celgene Corporation Business Overview
- 10.18.5 Celgene Corporation Recent Developments
- 10.19 Cellectis
- 10.19.1 Cellectis Basic Information
- 10.19.2 Cellectis Human Gene Therapy Product Overview
- 10.19.3 Cellectis Human Gene Therapy Product Market Performance
- 10.19.4 Cellectis Business Overview
- 10.19.5 Cellectis Recent Developments
- 10.20 Sangamo Therapeutics
- 10.20.1 Sangamo Therapeutics Basic Information
- 10.20.2 Sangamo Therapeutics Human Gene Therapy Product Overview
- 10.20.3 Sangamo Therapeutics Human Gene Therapy Product Market Performance
- 10.20.4 Sangamo Therapeutics Business Overview
- 10.20.5 Sangamo Therapeutics Recent Developments
- 10.21 Mustang Bio
- 10.21.1 Mustang Bio Basic Information
- 10.21.2 Mustang Bio Human Gene Therapy Product Overview
- 10.21.3 Mustang Bio Human Gene Therapy Product Market Performance
- 10.21.4 Mustang Bio Business Overview
- 10.21.5 Mustang Bio Recent Developments
- 10.22 AGTC
- 10.22.1 AGTC Basic Information
- 10.22.2 AGTC Human Gene Therapy Product Overview
- 10.22.3 AGTC Human Gene Therapy Product Market Performance
- 10.22.4 AGTC Business Overview
- 10.22.5 AGTC Recent Developments
- 10.23 Poseida Therapeutics
- 10.23.1 Poseida Therapeutics Basic Information
- 10.23.2 Poseida Therapeutics Human Gene Therapy Product Overview
- 10.23.3 Poseida Therapeutics Human Gene Therapy Product Market Performance
- 10.23.4 Poseida Therapeutics Business Overview
- 10.23.5 Poseida Therapeutics Recent Developments
- 10.1 Biogen
- 11 Human Gene Therapy Market Forecast by Region
- 11.1 Global Human Gene Therapy Market Size Forecast
- 11.2 Global Human Gene Therapy Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Human Gene Therapy Market Size Forecast by Country
- 11.2.3 Asia Pacific Human Gene Therapy Market Size Forecast by Region
- 11.2.4 South America Human Gene Therapy Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Human Gene Therapy by Country
- 12 Forecast Market by Type and by Application (2026-2035)
- 12.1 Global Human Gene Therapy Market Forecast by Type (2026-2035)
- 12.1.1 Global Forecasted Sales of Human Gene Therapy by Type (2026-2035)
- 12.1.2 Global Human Gene Therapy Market Size Forecast by Type (2026-2035)
- 12.1.3 Global Forecasted Price of Human Gene Therapy by Type (2026-2035)
- 12.2 Global Human Gene Therapy Market Forecast by Application (2026-2035)
- 12.2.1 Global Human Gene Therapy Sales (K MT) Forecast by Application
- 12.2.2 Global Human Gene Therapy Market Size (M USD) Forecast by Application (2026-2035)
- 12.1 Global Human Gene Therapy Market Forecast by Type (2026-2035)
- 13 Conclusion and Key Findings